Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | FLT1 | P17948 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4415224 | 0.89 | TSHR (0.40) | GRIN2CMTNR1BKMT2AMEN1SCD5 | |
| SCHEMBL13973322 | 0.82 | RXFP1 (0.32) | L3MBTL1HCRTR1HCRTR2RXFP1 | |
| SCHEMBL4416972 | 0.81 | GRIN2C (0.41) | GRIN2CHCRTR1HCRTR2MTNR1BKMT2A | |
| SCHEMBL4423047 | 0.80 | GRIN2C (0.51) | GRIN2CMTNR1BKMT2AMEN1NPSR1 | |
| SCHEMBL4416192 | 0.79 | GRIN2C (0.47) | GRIN2CMTNR1BKMT2AMEN1NPSR1 | |
| SCHEMBL4413447 | 0.79 | KMT2A (0.55) | GRIN2CKMT2AMEN1NPSR1LMNA | |
| SCHEMBL4418256 | 0.79 | KMT2A (0.52) | GRIN2CKMT2AMEN1NPSR1LMNA | |
| SCHEMBL6505108 | 0.79 | GRIN2C (0.40) | L3MBTL1GRIN2CMTNR1BKMT2AMEN1 | |
| SCHEMBL4417027 | 0.79 | MTNR1B (0.47) | HTTNPC1GRIN2CHCRTR1HCRTR2 | |
| SCHEMBL4418264 | 0.79 | MTNR1B (0.52) | GRIN2CHCRTR1HCRTR2MTNR1BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1663983-B1 | N-SUBSTITUTED, 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS | 4SC AG (DE) | 2009-01-21 | — | — | EP | disclosed |
| US-20050070570-A1 | Novel potassium channels modulators | 4SC AG (DE) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070570-A1 | Novel potassium channels modulators | HCN4, KCNA4, KCNN4 | HTT 1037/4885L3MBTL1 2533/4885NPC1 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.